Ascentage Pharma Group International (AAPG) Long-Term Deferred Tax (2022 - 2025)

Historic Long-Term Deferred Tax for Ascentage Pharma Group International (AAPG) over the last 4 years, with Q2 2025 value amounting to $4.7 million.

  • Ascentage Pharma Group International's Long-Term Deferred Tax changed N/A to $4.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.7 million, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2024, which is 1756.99% down from last year.
  • Latest data reveals that Ascentage Pharma Group International reported Long-Term Deferred Tax of $4.7 million as of Q2 2025.
  • In the past 5 years, Ascentage Pharma Group International's Long-Term Deferred Tax registered a high of $8.4 million during Q4 2022, and its lowest value of $4.7 million during Q2 2025.
  • For the 4-year period, Ascentage Pharma Group International's Long-Term Deferred Tax averaged around $6.9 million, with its median value being $7.2 million (2023).
  • In the last 5 years, Ascentage Pharma Group International's Long-Term Deferred Tax crashed by 85.65% in 2023 and then crashed by 2590.39% in 2024.
  • Quarter analysis of 4 years shows Ascentage Pharma Group International's Long-Term Deferred Tax stood at $8.4 million in 2022, then decreased by 0.86% to $8.3 million in 2023, then decreased by 25.9% to $6.2 million in 2024, then dropped by 24.33% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q2 2025, $6.2 million for Q4 2024, and $8.3 million during Q4 2023.